期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肠道菌群与非酒精性脂肪性肝病关系的研究进展 被引量：2

原文传递
导出
摘要 随着我国经济的发展和饮食结构的改变，非酒精性脂肪性肝病（nonalcoholic fatty liver disease，NAFLD）的发病率正逐年升高，已成为第一大肝脏疾病。NAFLD的发病机制尚未完全阐明，可能与胰岛素抵抗（insulin resistance，IR）和遗传易感密切相关。
作者 廖献花 邓丽芬 叶俊钊 钟碧慧
机构地区 中山大学附属第一医院消化科
出处 《中华消化杂志》 CAS CSCD 北大核心 2016年第9期643-645,共3页 Chinese Journal of Digestion
基金 国家自然科学基金（81170392） 广东省科技计划项目（20138021800290、2014A020212118） 中国肝炎防治基金（TQGB20140083）
关键词 非酒精性脂肪性肝病 肠道菌群 LIVER NAFLD 胰岛素抵抗 饮食结构 肝脏疾病 发病机制
分类号 R575.5 [医药卫生—消化系统]
  • 相关文献

参考文献3

二级参考文献46

  • 1Yan-Yan Ma,Lin Li,Chao-Hui Yu,Zhe Shen,Li-Hua Chen,You-Ming Li.Effects of probiotics on nonalcoholic fatty liver disease:A meta-analysis[J].World Journal of Gastroenterology,2013,19(40):6911-6918. 被引量：33
  • 2Ya-Ping Zhang Xi-Xian Yao Xia Zhao.Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells[J].World Journal of Gastroenterology,2006,12(9):1392-1396. 被引量：22
  • 3G. Musso,M. Cassader,F. Rosina,R. Gambino.Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials[J]. Diabetologia . 2012 (4)
  • 4Michele Malaguarnera,Marco Vacante,Tijana Antic,Maria Giordano,Giuseppe Chisari,Rosaria Acquaviva,Silvana Mastrojeni,Giulia Malaguarnera,Antonio Mistretta,Giovanni Volti,Fabio Galvano.Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis[J]. Digestive Diseases and Sciences . 2012 (2)
  • 5Pietro Vajro,Claudia Mandato,Maria Rosaria Licenziati,Adriana Franzese,Dino Franco Vitale,Selvaggia Lenta,Maria Caropreso,Gianfranco Vallone,Rosaria Meli.Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease[J]. Journal of Pediatric Gastroenterology and Nutrition . 2011 (6)
  • 6Mariano Malaguarnera,Maria Pia Gargante,Giulia Malaguarnera,Mario Salmeri,Silvana Mastrojeni,Liborio Rampello,Giovanni Pennisi,Giovanni Li Volti,Fabio Galvano.Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy[J]. European Journal of Gastroenterology & Hepatology . 2010 (2)
  • 7LiviaDe Fraia Pinto,Cecília MelletiCompri,Jo?o VictorFornari,WaldemarBartchewsky,Dennys EduardoCintra,MiriamTrevisan,PatríciaDe Oliveira Carvalho,Marcelo LimaRibeiro,Licio A.Velloso,Mario J.Saad,JoséPedrazzoli,AlessandraGambero.The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high‐fat diet in mice[J]. Liver International . 2010 (4)
  • 8Mary E. Rinella,Sean Koppe,Elizabeth M. Brunt,Marc Elias,Jeanne Gottstein,Richard M. Green.563 Pentoxifylline Improves ALT and Histology in Patients with NASH, a Double Blind Placebo Controlled Trial[J]. Gastroenterology . 2009 (5)
  • 9Piotr Socha,Andrea Horvath,Pietro Vajro,Piotr Dziechciarz,Anil Dhawan,Hania Szajewska.Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review[J]. Journal of Pediatric Gastroenterology and Nutrition . 2009 (5)
  • 10P. D. Cani,A. M. Neyrinck,F. Fava,C. Knauf,R. G. Burcelin,K. M. Tuohy,G. R. Gibson,N. M. Delzenne.Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia[J]. Diabetologia . 2007 (11)

共引文献158

同被引文献35

引证文献2

二级引证文献14

中华消化杂志
2016年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部